Vigil Neuroscience, Inc. (VIGL)
Aug 5, 2025 - VIGL was delisted (reason: acquired by SNY)
8.05
0.00 (0.00%)
Inactive · Last trade price
on Aug 4, 2025
Vigil Neuroscience Employees
Vigil Neuroscience had 69 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
69
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,335,725
Market Cap
383.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 69 | 0 | - |
| Dec 31, 2023 | 69 | 13 | 23.21% |
| Dec 31, 2022 | 56 | - | - |
VIGL News
- 4 weeks ago - VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL - Business Wire
- 2 months ago - Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP - GlobeNewsWire
- 3 months ago - Sanofi to Buy Vigil Neuroscience for About $470 Million - WSJ
- 3 months ago - Vigil Neuroscience Enters into Definitive Merger Agreement to be Acquired by Sanofi - GlobeNewsWire
- 3 months ago - Sanofi to acquire Vigil Neuroscience in $470 million deal - Reuters
- 3 months ago - Press Release: Sanofi to acquire Vigil Neuroscience, Inc., adding a new investigational medicine to treat Alzheimer's disease to the neurology pipeline - GlobeNewsWire
- 3 months ago - Vigil Neuroscience Reports First Quarter 2025 Financial Results and Provides Recent Business Updates - GlobeNewsWire
- 4 months ago - Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference - GlobeNewsWire